GenCanna is a pioneering company founded in 2011, headquartered in the United States, and operating in the Agriculture and Health Care industries. Focused on infusing innovation into their products, they offer high-quality hemp-derived CBD ingredients, including isolates, distillates, water-soluble liquids, custom formulations, private label programs, and more.
With a proven track record, GenCanna has been at the forefront of the booming CBD industry since its inception. The company played a vital role in the introduction of Kentucky's Hemp Pilot Program in 2014, showcasing its commitment to industry growth and compliance. GenCanna's dedication to excellence is reflected in the premium quality of their products, earning them the highest industry certifications and compliance accreditations.
The latest investment round of $30.00M came from MariMed on 12 November 2018, highlighting the confidence in GenCanna's potential. As the company continues to lead in innovation and regulatory initiatives, it presents a promising opportunity for investors seeking growth in the CBD market.
GenCanna's focus on reliability, innovation, and premium CBD ingredients positions it as a key player in the industry, offering profitable solutions for businesses across various sectors, including food and beverage, cosmetics, health and wellness, and pet products.